Davita Inc (NYSE:DVA) – William Blair boosted their Q1 2020 earnings per share estimates for Davita in a report issued on Tuesday, February 11th. William Blair analyst M. Larew now expects that the company will post earnings of $1.45 per share for the quarter, up from their prior forecast of $1.22. William Blair also issued estimates for Davita’s Q3 2020 earnings at $1.43 EPS, Q4 2020 earnings at $1.57 EPS and FY2020 earnings at $6.03 EPS.
Several other research analysts have also recently weighed in on DVA. SunTrust Banks set a $90.00 price objective on Davita in a research report on Tuesday. ValuEngine raised Davita from a “strong sell” rating to a “sell” rating in a research report on Wednesday, January 15th. Zacks Investment Research raised Davita from a “hold” rating to a “strong-buy” rating and set a $93.00 price objective for the company in a research report on Wednesday. Deutsche Bank began coverage on Davita in a research report on Friday, January 3rd. They set a “buy” rating and a $60.00 price objective for the company. Finally, Goldman Sachs Group raised Davita from a “neutral” rating to a “buy” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $71.43.
DVA stock opened at $85.98 on Friday. The company has a debt-to-equity ratio of 4.26, a current ratio of 1.81 and a quick ratio of 1.77. The stock has a market capitalization of $11.00 billion, a P/E ratio of 16.01, a P/E/G ratio of 0.63 and a beta of 1.70. The business has a 50-day moving average of $79.34 and a 200-day moving average of $66.99. Davita has a fifty-two week low of $43.40 and a fifty-two week high of $90.15.
Davita (NYSE:DVA) last posted its earnings results on Monday, February 10th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.66 by $0.20. Davita had a return on equity of 22.93% and a net margin of 7.12%. The firm had revenue of $2.90 billion during the quarter, compared to analysts’ expectations of $2.92 billion. During the same period in the previous year, the firm earned $0.90 earnings per share. The company’s revenue was up 2.7% on a year-over-year basis.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Resources Management Corp CT ADV acquired a new position in Davita during the third quarter valued at approximately $33,000. Duncker Streett & Co. Inc. acquired a new position in Davita during the fourth quarter valued at approximately $47,000. NuWave Investment Management LLC boosted its position in Davita by 1,166.3% during the third quarter. NuWave Investment Management LLC now owns 1,013 shares of the company’s stock valued at $57,000 after purchasing an additional 933 shares during the last quarter. Benjamin F. Edwards & Company Inc. acquired a new position in Davita during the third quarter valued at approximately $68,000. Finally, Vestcor Investment Management Corp acquired a new position in Davita during the fourth quarter valued at approximately $117,000. 95.40% of the stock is owned by hedge funds and other institutional investors.
Davita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
See Also: Market Indexes
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.